Brinks, H., Rohde, D., Voelkers, M., Qiu, G., Pleger, S. T., Herzog, N., … Most, P. (2010). S100A1 Genetically-targeted Therapy Reverses Dysfunction of Human Failing Myocardium. In CIRCULATION (Vol. 122).

Brinks, Henriette, David Rohde, Mirko Voelkers, Gang Qiu, Sven T. Pleger, Nicole Herzog, Joseph Rabinowitz, et al. “S100A1 Genetically-targeted Therapy Reverses Dysfunction of Human Failing Myocardium.” In CIRCULATION, Vol. 122, 2010.

Brinks H, Rohde D, Voelkers M, Qiu G, Pleger ST, Herzog N, et al. S100A1 Genetically-targeted Therapy Reverses Dysfunction of Human Failing Myocardium. In: CIRCULATION. 2010.

Brinks, Henriette, et al. “S100A1 Genetically-targeted Therapy Reverses Dysfunction of Human Failing Myocardium.” CIRCULATION, vol. 122, no. 21, 2010.

Brinks H, Rohde D, Voelkers M, Qiu G, Pleger ST, Herzog N, Rabinowitz J, Ruhparwar A, Silvestry S, Kraus C, Mather PJ, Eckhart AD, Katus HA, Koch WJ, Most P. S100A1 Genetically-targeted Therapy Reverses Dysfunction of Human Failing Myocardium. CIRCULATION. 2010.